Small particle drug-eluting beads-transarterial chemoembolization combined with targeted therapy in the clinical treatment of unresectable liver cancer

Table 1 Comparison of baseline data in the two groups

Characteristics		Control group, n = 36	Joint group, n = 38	χ2/t	P value
Sex	Male	19	21	0.046	0.830
	Female	17	17
Age in years	-	54.26 ± 6.18	53.99 ± 6.03	0.190	0.850
Number of tumors	1	12	15	0.820	0.664
	2	7	9
	≥ 3	17	14
Maximum tumor diameter in cm	-	8.13 ± 0.65	8.40 ± 0.72	1.690	0.095
HBV-DNA in IU/mL	≤ 100	20	15	1.918	0.166
	> 100	16	23
Child-Pugh grading[13]	A	28	24	1.891	0.169
	B	8	14	1.921	0.383
ECOG scores in points[14]	0	15	20
	1	16	11
	2	5	7
PVTT	Presence	9	12	0.394	0.530
	Absence	27	26

Data are n or mean ± SD. ECOG: Eastern Cooperative Oncology Group performance status; HBV: Hepatitis B virus; PVTT: Portal vein tumor thrombus.